Perception Neuroscience
Pre-clinicalDevelops novel therapeutics targeting the NMDA receptor for treatment-resistant depression and other neuropsychiatric disorders.
Founded
2018
Focus
Small MoleculesPsychedelics
About
Develops novel therapeutics targeting the NMDA receptor for treatment-resistant depression and other neuropsychiatric disorders.
Funding History
1Total raised: $8M
Series A$8MSamsara BioCapitalJun 15, 2018
Company Info
TypePrivate
Founded2018
LocationNew York, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile